Biomarker Testing Awareness Month
March 2027. Part of the Test Before Treatment campaign.
biomarkertestingawarenessmonth.org ↗ Site live
Oncology
Cancer care is failing too many of us.
We aren't getting tested and treated fast enough.
The burden
2.1 million
people in the U.S. expected to be diagnosed with cancer in 20261
626,000
expected to die from cancer in 20261
69%
of untested cancer patients say biomarker testing was never discussed with them2
Sources
- American Cancer Society. Cancer Facts & Figures 2026.
- American Cancer Society Cancer Action Network. Survivor Views: Biomarker Testing. 2023.
Figures as stated by each source; checked November 2026.
Rabble response
Close the testing gap.
Rabble Health works on both sides of the testing gap: awareness that moves people to get tested, and programs that make testing part of care.
FAST
Facilitating Access to Sequencing & Testing: biomarker testing that leads to the right treatment.
Key dates in Oncology
Moments to act together.
Next six months. Dates from official sites; checked November 2026. Programs run in the United States. Global congresses and world days are listed for reference.
Work with us in Oncology
Patients can't wait. Neither can we.
Reach more patients at the right time.
Publish measurable improvement in patient care.
Close the gap between eligible patients and guideline-based care.
What's new in Oncology
How care is changing.
Updated weekly from federal agencies, guideline bodies and national nonprofits. U.S. sources for now, while programs run in the United States. Approvals are listed by date from FDA notices. Rabble Health may work with companies whose products appear here; no company reviews or influences what is listed.
Talk to us
Bring us a care gap.
Tell us where patients are falling out of care.
connect@rabblehealth.com